Avadel Pharmaceuticals News and Activities

Presence

Avadel Pharmaceuticals develops and sells medicines for sleep and central nervous system conditions. Its products and drug development services support patients, healthcare providers, and specialty care markets.

Avadel Pharmaceuticals products and services overview:

Sleep medicines
CNS therapies
Prescription drugs
Drug development

Revenue: ~$200 million

Employees: 160

Headquarters: Dublin, Ireland

Avadel Pharmaceuticals is one of the...

Avadel Pharmaceuticals is a company listed under the stock ticker AVDL (US).

Acquisition, funding and merger involving Avadel Pharmaceuticals.

Alkermes has announced the acquisition of Avadel Pharmaceuticals (posted on November 19 2025).

Executives

View the org chart displaying its 12 main executives

Most searched biographies at Avadel Pharmaceuticals

Popular executive movements at Avadel Pharmaceuticals

David O'Brien, Head, Market Insight and Commercial Analytics, has left the company (posted on May 20 2026).
Jennifer Gudeman, Senior Vice President, Medical and Clinical Affairs, has left the company (posted on May 19 2026).

Create your alert
to follow the executive moves at Avadel Pharmaceuticals.